MEDICUS PHARMA LTD (MDCX) Stock Analyst Ratings
USA - NASDAQ:MDCX - CA58471K2020 - Common Stock
2.39 USD
-0.03 (-1.24%)
2.4399 USD
+0.05 (+2.09%)
ChartMill assigns a Buy % Consensus number of 82% to MDCX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.78. This target is 853.14% above the current price.
MDCX was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDCX.
In the previous month the buy percentage consensus was at a similar level.
MDCX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-10-14 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-09-02 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-07-01 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-29 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-08 | Maxim Group | Maintains | Buy -> Buy |
| 2025-04-28 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-21 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-14 | D. Boral Capital | Initiate | Buy |
| 2024-12-17 | Maxim Group | Initiate | Buy |
MEDICUS PHARMA LTD / MDCX FAQ
What do analysts expect the price target to be for MEDICUS PHARMA LTD (MDCX)?
9 analysts have analysed MDCX and the average price target is 22.78 USD. This implies a price increase of 853.14% is expected in the next year compared to the current price of 2.39.
How do analysts rate MEDICUS PHARMA LTD (MDCX)?
The consensus rating for MEDICUS PHARMA LTD (MDCX) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.